Multiple loci identified in a genome-wide association study of prostate cancer

Gilles Thomas; Kevin B Jacobs; Meredith Yeager; Peter Kraft; Sholom Wacholder; Nick Orr; Kai Yu; Nilanjan Chatterjee; Robert Welch; Amy Hutchinson; Andrew Crenshaw; Geraldine Cancel-Tassin; Brian J Staats; Zhaoming Wang; Jesus Gonzalez-Bosquet; Jun Fang; Xiang Deng; Sonja I Berndt; Eugenia E Calle; Heather Spencer Feigelson; Michael J Thun; Carmen Rodriguez; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Fredrick R Schumacher; Edward Giovannucci; Walter C Willett; Olivier Cussenot; Antoine Valeri; Gerald L Andriole; E David Crawford; Margaret Tucker; Daniela S Gerhard; Robert Hoover; Richard B Hayes; David J Hunter; Stephen J Chanock; Joseph F Fraumeni Jr

doi:10.1038/ng.91

Back

Multiple loci identified in a genome-wide association study of prostate cancer

Journal article

Peer reviewed

Multiple loci identified in a genome-wide association study of prostate cancer

Gilles Thomas, Kevin B Jacobs, Meredith Yeager, Peter Kraft, Sholom Wacholder, Nick Orr, Kai Yu, Nilanjan Chatterjee, Robert Welch, Amy Hutchinson, …

Nature genetics, Vol.40(3), pp.310-315

03/2008

DOI: 10.1038/ng.91

PMID: 18264096

View Online

Abstract

We followed our initial genome-wide association study (GWAS) of 527,869 SNPs on 1,172 individuals with prostate cancer and 1,157 controls of European origin-nested in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial prospective study-by testing 26,958 SNPs in four independent studies (total of 3,941 cases and 3,964 controls). In the combined joint analysis, we confirmed three previously reported loci (two independent SNPs at 8q24 and one in HNF1B (formerly known as TCF2 on 17q); P < 10(-10)). In addition, loci on chromosomes 7, 10 (two loci) and 11 were highly significant (between P < 7.31 x 10(-13) and P < 2.14 x 10(-6)). Loci on chromosome 10 include MSMB, which encodes beta-microseminoprotein, a primary constituent of semen and a proposed prostate cancer biomarker, and CTBP2, a gene with antiapoptotic activity; the locus on chromosome 7 is at JAZF1, a transcriptional repressor that is fused by chromosome translocation to SUZ12 in endometrial cancer. Of the nine loci that showed highly suggestive associations (P < 2.5 x 10(-5)), four best fit a recessive model and included candidate susceptibility genes: CPNE3, IL16 and CDH13. Our findings point to multiple loci with moderate effects associated with susceptibility to prostate cancer that, taken together, in the future may predict high risk in select individuals.

European Continental Ancestry Group - genetics

Genetic Predisposition to Disease

Gene Frequency

Humans

Male

Chromosome Mapping

Phosphoproteins - genetics

Case-Control Studies

Linkage Disequilibrium

Prostatic Neoplasms - genetics

DNA Mutational Analysis

Interleukin-16 - genetics

Polymorphism, Single Nucleotide

Cadherins - genetics

Genome, Human

Quantitative Trait Loci

Genetic Linkage

Details

Title: Subtitle: Multiple loci identified in a genome-wide association study of prostate cancer
Creators: Gilles Thomas - Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA
Kevin B Jacobs
Meredith Yeager
Peter Kraft
Sholom Wacholder
Nick Orr
Kai Yu
Nilanjan Chatterjee
Robert Welch
Amy Hutchinson
Andrew Crenshaw
Geraldine Cancel-Tassin
Brian J Staats
Zhaoming Wang
Jesus Gonzalez-Bosquet
Jun Fang
Xiang Deng
Sonja I Berndt
Eugenia E Calle
Heather Spencer Feigelson
Michael J Thun
Carmen Rodriguez
Demetrius Albanes
Jarmo Virtamo
Stephanie Weinstein
Fredrick R Schumacher
Edward Giovannucci
Walter C Willett
Olivier Cussenot
Antoine Valeri
Gerald L Andriole
E David Crawford
Margaret Tucker
Daniela S Gerhard
Robert Hoover
Richard B Hayes
David J Hunter
Stephen J Chanock
Joseph F Fraumeni Jr
Resource Type: Journal article
Publication Details: Nature genetics, Vol.40(3), pp.310-315
Publisher: United States
DOI: 10.1038/ng.91
PMID: 18264096
ISSN: 1546-1718
eISSN: 1546-1718
Grant note: The Prostate Lung Colorectal Ovarian Cancer Screening Trial (PLCO) was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and by contracts from the Division of Cancer Prevention, National Cancer Institute, US National Institutes of Health, Department of Health and Human Services. The Health Professionals Follow-up Study (HPFS) study is supported by the US National Institutes of Health grant CA55075 and U01CA098233. The American Cancer Society (ACS) study is supported by U01 CA098710. The Alpha Tocopherol Beta-Carotene Cancer Prevention study (ATBC) Study is supported by the Intramural Research Program of the National Cancer Institute, NIH, and by US Public Health Service contracts N01-CN-45165, N01-RC-45035, and N01-RC-37004 from the National Cancer Institute, Department of Health and Human Services. F.R.S. is supported by a NRSA training-grant (T32 CA 09001). Centre de Recherche pour les Pathologies Prostatiques (CeRePP) thanks J.P.B. and Generali for their charitable donations which have contributed to this project. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.
Language: English
Date published: 03/2008
Academic Unit: Obstetrics and Gynecology
Record Identifier: 9983930281402771

Metrics

20 Record Views

753 Times Cited - Web of Science

See more details